Methoden vergleichen

	Sequential Organ Failure Assessment Score	APACHE II Score	qSOFA Score
Fachgebiet	Klinische Diagnostik	Klinische Diagnostik	Klinische Diagnostik
Familie	Process / pipeline	Process / pipeline	Process / pipeline
Entstehungsjahr	1996	1985	2016
Urheber	Jean-Louis Vincent and Rui Moreno	William A. Knaus, et al.	Sepsis-3 Taskforce
Typ	Organ dysfunction and sepsis assessment	ICU severity and mortality prediction	Rapid sepsis screening
Wegweisende Quelle	Vincent, J. L., Moreno, R., Takala, J., et al. (1996). The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfuncti on/failure. Intensive Care Medicine, 22(7), 707-710.	Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine, 13(10), 818-829.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Aliasnamen	SOFA, Sepsis-related Organ Failure Assessment	APACHE-II, APACHE2	Quick SOFA, qSOFA
Verwandt	3	3	3
Zusammenfassung	The Sequential Organ Failure Assessment (SOFA) score, introduced by Vincent and Moreno in 1996, is a 24-point daily assessment tool that quantifies organ dysfunction across six physiological systems in critically ill patients. It was adopted into the 2016 Sepsis-3 definitions and is now the international standard for identifying and grading sepsis-related organ failure.	The Acute Physiology and Chronic Health Evaluation (APACHE) II score, introduced by Knaus et al. in 1985, is a 71-point severity of illness classification system for critically ill patients. It combines acute physiological parameters, age, and chronic health status to predict intensive care unit (ICU) mortality, facilitating patient risk stratification and research standardization.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.